LifeMD
LFMD
40 hedge funds and large institutions have $11.3M invested in LifeMD in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 9 closing their positions.
1.12% more ownership
Funds ownership: 16.82% → 17.94% (+1.1%)
4% more call options, than puts
Call options by funds: $231K | Put options by funds: $222K
11% less funds holding
Funds holding: 45 → 40 (-5)
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
42% less capital invested
Capital invested by funds: $19.3M → $11.3M (-$8M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$1.47M |
| 2 |
SCM
Shah Capital Management
Raleigh,
North Carolina
|
+$861K |
| 3 |
FLPIM
F.L. Putnam Investment Management
Lynnfield,
Massachusetts
|
+$323K |
| 4 |
ACA
Anchor Capital Advisors
Boston,
Massachusetts
|
+$90.9K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$70.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$519K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$221K |
| 3 |
Two Sigma Investments
New York
|
-$200K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$195K |
| 5 |
Two Sigma Advisers
New York
|
-$178K |
LFMD Hedge Fund Activity: Q2 2022 in Review
40 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q2 2022, worth a combined $11.3M — down 42% from $19.3M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of LFMD and 5 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 10 added.
The largest buyer was Royce & Associates, opening a new position worth an estimated $1.47M. The largest seller was GSA Capital Partners, exiting entirely with an estimated $519K sold.
- 40 institutional investors held LifeMD (LFMD) as of Q2 2022, down from 45 in Q1 2022.
- Funds reported $11.3M of LifeMD stock for Q2 2022, down 42% quarter-over-quarter.
- 5 funds opened new LifeMD positions in Q2 2022 and 9 closed out, a net change of -4 holders.
- The largest LifeMD buyer in Q2 2022 was Royce & Associates, an estimated $1.47M added.
- The largest LifeMD seller in Q2 2022 was GSA Capital Partners, an estimated $519K sold.
Based on aggregated 13F filings for Q2 2022.